I. Novel HCV NS5B polymerase inhibitors: Discovery of indole 2-carboxylic acids with C3-heterocycles

被引：46

作者：

Anilkumar, Gopinadhan N. ^{[1
]}

Lesburg, Charles A. ^{[1
]}

Selyutin, Oleg ^{[1
]}

Rosenblum, Stuart B. ^{[1
]}

Zeng, Qingbei ^{[1
]}

Jiang, Yueheng ^{[1
]}

Chan, Tin-Yau ^{[1
]}

Pu, Haiyan ^{[1
]}

Vaccaro, Henry ^{[1
]}

Wang, Li ^{[1
]}

Bennett, Frank ^{[1
]}

Chen, Kevin X. ^{[1
]}

Duca, Jose ^{[1
]}

Gavalas, Stephen ^{[1
]}

Huang, Yuhua ^{[1
]}

Pinto, Patrick ^{[1
]}

Sannigrahi, Mousumi ^{[1
]}

Velazquez, Francisco ^{[1
]}

Venkatraman, Srikanth ^{[1
]}

Vibulbhan, Bancha ^{[1
]}

Agrawal, Sony ^{[1
]}

Butkiewicz, Nancy ^{[1
]}

Feld, Boris ^{[1
]}

Ferrari, Eric ^{[1
]}

He, Zhiqing ^{[1
]}

Jiang, Chuan-kui ^{[1
]}

Palermo, Robert E. ^{[1
]}

Mcmonagle, Patricia ^{[1
]}

Huang, H. -C. ^{[1
]}

Shih, Neng-Yang ^{[1
]}

Njoroge, George ^{[1
]}

Kozlowski, Joseph A. ^{[1
]}

机构：

[1] Merck Res Labs, Kenilworth, NJ 07033 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2011年 / 21卷 / 18期

关键词：

HCV; NS5B polymerase; HEPATITIS-C VIRUS; DEPENDENT RNA-POLYMERASE; CRYSTAL-STRUCTURE; INFECTION;

D O I：

10.1016/j.bmcl.2011.07.021

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

SAR development of indole-based palm site inhibitors of HCV NS5B polymerase exemplified by initial indole lead 1 (NS5B IC(50) = 0.9 mu M, replicon EC(50) > 100 mu M) is described. Structure-based drug design led to the incorporation of novel heterocyclic moieties at the indole C3-position which formed a bidentate interaction with the protein backbone. SAR development resulted in leads 7q (NS5B IC(50) = 0.032 mu M, replicon EC(50) = 1.4 mu M) and 7r (NS5B IC(50) = 0.017 mu M, replicon EC(50) = 0.3 mu M) with improved enzyme and replicon activity. (C) 2011 Elsevier Ltd. All rights reserved.

引用

页码：5336 / 5341

页数：6

共 50 条

[1] Novel HCV NS5B polymerase inhibitors: Discovery of indole 2-carboxylic acids with C3-heterocycles
Anilkumar, Gopinadhan N.
Lesburg, Charles
Selyutin, Oleg
Rosenblum, Stuart B.
Zeng, Qingbei
Jiang, Yueheng
Chan, Tin-Yau
Pu, Haiyan
Vaccaro, Henry
Wang, Li
Bennet, Frank
Chen, Kevin X.
Duca, Jose
Gavalas, Stephen
Huang, Yuhua
Pinto, Patrick
Sannigrahi, Mousumi
Velazquez, Francisco
Venkatraman, Srikanth
Vibulbhan, Bancha
Agrawal, Sony
Butkiewicz, Nancy
Ferrari, Eric
Feld, Boris
He, Zhiqing
Jiang, Chuan-kui
Palermo, Robert E.
Huang, H. -C.
Shih, Neng-Yang
Njoroge, George
Kozlowski, Joseph A.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
[2] Novel HCV NS5B polymerase inhibitors: Discovery of indole C2-acyl sulfonamides
Anilkumar, Gopinadhan N.
Selyutin, Oleg
Rosenblum, Stuart B.
Zeng, Qingbei
Jiang, Yueheng
Torres, Luis
Chan, Tin-Yau
Pu, Haiyan
Vaccaro, Henry
Wang, Li
Bennet, Frank
Chen, Kevin X.
Gavalas, Stephen
Huang, Yuhua
Pinto, Patrick
Sannigrahi, Mousumi
Velazquez, Francisco
Venkatraman, Srikanth
Vibulbhan, Bancha
Lesburg, Charles
Duca, Jose
McNemar, Charles
Agrawal, Sony
Ferrari, Eric
Jiang, Chuan-kui
Huang, H-C
Shih, Neng-Yang
Njoroge, George
Kozlowski, Joseph A.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
[3] II. Novel HCV NS5B polymerase inhibitors: Discovery of indole C2 acyl sulfonamides
Anilkumar, Gopinadhan N.
Selyutin, Oleg
Rosenblum, Stuart B.
Zeng, Qingbei
Jiang, Yueheng
Chan, Tin-Yau
Pu, Haiyan
Wang, Li
Bennett, Frank
Chen, Kevin X.
Lesburg, Charles A.
Duca, Jose
Gavalas, Stephen
Huang, Yuhua
Pinto, Patrick
Sannigrahi, Mousumi
Velazquez, Francisco
Venkatraman, Srikanth
Vibulbhan, Bancha
Agrawal, Sony
Ferrari, Eric
Jiang, Chuan-kui
Huang, H. -C.
Shih, Neng-Yang
Njoroge, F. George
Kozlowski, Joseph A.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (01) : 713 - 717
[4] DISCOVERY OF NOVEL HCV NS5B POLYMERASE INHIBITORS BY IN SILICO APPROACHES
Karaman Mayack, Berin
JOURNAL OF RESEARCH IN PHARMACY, 2023, 27 : 13 - 15
[5] Discovery of novel tricyclic indole derived inhibitors of HCV NS5B RNA dependent RNA polymerase
Venkatraman, Srikanth
Velazquez, Francisco
Gavalas, Stephen
Wu, Wanli
Chen, Kevin X.
Nair, Anilkumar G.
Bennett, Frank
Huang, Yuhua
Pinto, Patrick
Jiang, Yueheng
Selyutin, Oleg
Vibulbhan, Bancha
Zeng, Qingbei
Lesburg, Charles
Duca, Jose
Huang, Hsueh-Cheng
Agrawal, Sony
Jiang, Chuan-kui
Ferrari, Eric
Li, Cheng
Kozlowski, Joseph
Rosenblum, Stuart
Shih, Neng-Yang
Njoroge, F. George
BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (07) : 2007 - 2017
[6] Chemical genetics-based discovery of indole derivatives as HCV NS5B polymerase inhibitors
Jin, Guanghai
Lee, Sungjin
Choi, Moonju
Son, Seohyun
Kim, Geon-Woo
Oh, Jong-Won
Lee, Choongho
Lee, Kyeong
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 75 : 413 - 425
[7] The activity prediction of indole inhibitors against HCV NS5B polymerase
Muhire, Jules
Zhai, Hong Lin
Lu, Shao Hua
Li, Sha Sha
Yin, Bo
Mi, Jia Ying
CHEMICAL BIOLOGY & DRUG DESIGN, 2020, 95 (02) : 240 - 247
[8] Discovery of Terpenes as Novel HCV NS5B Polymerase Inhibitors via Molecular Docking
Karpinski, Tomasz. M. M.
Ozarowski, Marcin
Silva, Pedro. J. J.
Stasiewicz, Mark
Alam, Rahat
Samad, Abdus
PATHOGENS, 2023, 12 (06):
[9] Hepatitis C therapy with HCV NS5B polymerase inhibitors
Soriano, Vincent
Vispo, Eugenia
de Mendoza, Carmen
Labarga, Pablo
Vicente Fernandez-Montero, Jose
Poveda, Eva
Trevino, Ana
Barreiro, Pablo
EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (09) : 1161 - 1170
[10] Discovery of new scaffolds for rational design of HCV NS5B polymerase inhibitors
Golub, Andriy G.
Gurukumar, K. R.
Basu, Amartya
Bdzhola, Volodymyr G.
Bilokin, Yaroslav
Yarmoluk, Sergiy M.
Lee, Jin-Ching
Talele, Tanaji T.
Nichols, Daniel B.
Kaushik-Basu, Neerja
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 58 : 258 - 264

← 1 2 3 4 5 →